Barrington Research Maintains Outperform on US Physical Therapy, Maintains $108 Price Target
Portfolio Pulse from Benzinga Newsdesk
Barrington Research has reiterated its 'Outperform' rating for US Physical Therapy (NYSE:USPH) with a maintained price target of $108, indicating confidence in the company's future performance.
September 20, 2024 | 3:36 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Barrington Research has reiterated its 'Outperform' rating for US Physical Therapy with a maintained price target of $108, suggesting positive expectations for the company's stock performance.
The reaffirmation of an 'Outperform' rating and a specific price target of $108 by Barrington Research indicates a positive outlook for USPH. This can lead to increased investor confidence and potential upward movement in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100